Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Times Leader
Click for weather forecast
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Adamas Pharma
(NQ:
ADMS
)
5.163
USD
+0.133 (+2.65%)
Streaming Delayed Price
Updated: 3:03 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Adamas Pharma
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SRPT
ICLR
BMRN
From
Benzinga
Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
February 24, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
February 24, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
First Week of April 16th Options Trading For Adamas Pharmaceuticals (ADMS)
February 24, 2021
Investors in Adamas Pharmaceuticals Inc (ADMS) saw new options begin trading this week, for the April 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADMS...
Tags
Stocks
From
Market News Video
Adamas Pharmaceuticals: Q4 Earnings Insights
February 23, 2021
Shares of Adamas Pharmaceuticals (NASDAQ:ADMS) rose in after-market trading after the company reported Q4 results. Quarterly ...
Tags
Market News
Earnings
Benzinga
From
Benzinga
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
February 23, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported...
From
Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
INSP
ARDS
MDT
From
Benzinga
Earnings Scheduled For February 23, 2021
February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ...
Tags
ALC
FLS
AXDX
From
Benzinga
A Preview Of Adamas Pharmaceuticals's Earnings
February 22, 2021
Adamas Pharmaceuticals (NASDAQ:ADMS) announces its next round of earnings this Tuesday, February 23. Here is Benzinga's ...
Tags
Market News
Earnings
BZI/EP
From
Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
MDT
CNCE
NKTR
From
Benzinga
Adamas to Present at Upcoming Healthcare Conferences
February 17, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced...
From
Business Wire News Releases
Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021
February 10, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, after market close....
From
Business Wire News Releases
90 Biggest Movers From Yesterday
February 03, 2021
Gainers Cassava Sciences, Inc.. (NASDAQ: SAVA) shares jumped 141.2% to close at $55.44 on Tuesday after the company announced ...
Tags
JRJC
SIEB
EXK
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 02, 2021
Gainers Cassava Sciences (NASDAQ:SAVA) stock moved upwards by 123.66% to $51.42 during Tuesday's regular session. As ...
Tags
AEZS
Top Gainers
IMVT
From
Benzinga
60 Stocks Moving In Tuesday's Mid-Day Session
February 02, 2021
Gainers Lizhi Inc. (NASDAQ: LIZI) shares climbed 64.6% to $6.01. American Resources Corporation (NASDAQ: AREC) gained 56% to ...
Tags
ADMS
ATOS
MUX
From
Benzinga
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment
February 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IBB
VRTX
NLSP
From
Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
February 02, 2021
Gainers Artelo Biosciences, Inc. (NASDAQ: ARTL) shares rose 126.9% to $2.36 in pre-market trading after climbing over 8% on ...
Tags
BFIN
BDR
CRBP
From
Benzinga
102 Biggest Movers From Yesterday
February 02, 2021
Gainers Leisure Acquisition Corp. (NASDAQ: LACQ) shares jumped 111.2% to close at $23.99 on Monday after the company entered into ...
Tags
News
SFIX
YGMZ
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 01, 2021
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 16.59% to $2.6 during Monday's after-market session. This ...
Tags
ARQT
ADMA
Benzinga
From
Benzinga
Adamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
February 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it...
From
Business Wire News Releases
70 Stocks Moving In Monday's Mid-Day Session
February 01, 2021
Gainers Viela Bio, Inc. (NASDAQ: VIE) shares surged 52.6% to $52.91 after the company agreed to be acquired by Horizon ...
Tags
VBIV
AIRT
YQ
From
Benzinga
Adamas Announces Settlement of Patent Litigation with Zydus
February 01, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today...
From
Business Wire News Releases
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
January 31, 2021
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of ...
Tags
GTHX
TGTX
Market News
From
Benzinga
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
January 30, 2021
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all...
Tags
Stocks / Equities
Healthcare
Pharma/Biotech
From
Blogs - TalkMarkets
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
January 30, 2021
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick ...
Tags
VIVO
NBIX
Penny Stocks
From
Benzinga
100 Biggest Movers From Yesterday
January 27, 2021
Gainers EZGO Technologies Ltd(NASDAQ: EZGO) shares jumped around 352.8% to close at $18.11on Tuesday after the company ...
Tags
BZUN
NKLA
ECOR
From
Benzinga
55 Stocks Moving In Tuesday's Mid-Day Session
January 26, 2021
Gainers Oxbridge Re Holdings Limited (NASDAQ: OXBR) gained 65% to $3.96. Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 62.6% ...
Tags
EXPR
KOSS
USWS
From
Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
January 26, 2021
Gainers Koss Corporation (NASDAQ: KOSS) shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the ...
Tags
LAIX
ATOS
Health Care
From
Benzinga
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
January 13, 2021
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.